NSIM
RDY icon

North Star Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

North Star Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07K Sell
74
-772
-91% -$10.4K ﹤0.01% 1530
2026
Q1 		$11.7K Buy
846
+269
+47% +$3.75K ﹤0.01% 990
2025
Q4 		$8.1K Buy
577
+543
+1,597% +$7.62K ﹤0.01% 998
2025
Q3 		$475 Buy
+34
New +$489 ﹤0.01% 1264

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FRA
Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

North Star Investment Management's RDY Position: Q2 2026 in Review

North Star Investment Management reduced its Dr. Reddy's Laboratories (RDY) stake by 91% in Q2 2026, selling an estimated $10.4K and leaving 74 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

North Star Investment Management first reported a position in RDY in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.7K in Q1 2026. 58 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • North Star Investment Management held 74 shares of Dr. Reddy's Laboratories worth $1.07K as of Q2 2026.
  • North Star Investment Management sold 772 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $10.4K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1530 holding.
  • North Star Investment Management first reported a position in Dr. Reddy's Laboratories in Q3 2025 and has held it in 4 quarters since.
  • North Star Investment Management's Dr. Reddy's Laboratories position peaked at $11.7K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.